| Myxoid Liposarcoma studied in …STUDIED_INderived31 of 31show fewer |
|---|
| → studied in | NCT07686367Phase 2 · not yet recruiting Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers · condition mapped CURATED_BROADER · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843967Phase 1/Phase 2 · recruiting A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07261657early Phase 1 · recruiting N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044768Phase 2 · active not recruiting Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06617572available Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06083883Phase 1 · recruiting Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414434Phase 1 · active not recruiting BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132922Phase 1 · active not recruiting MAGE-A4ᶜ¹º³²T for Multi-Tumor · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05492682Phase 1 · recruiting START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04794127Phase 2 · completed Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05120271Phase 1/Phase 2 · active not recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06748872Phase 1 · not yet recruiting EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03670069Phase 1 · terminated Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas · condition mapped CURATED_BROADER · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600649Phase 1 · unknown Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063632Phase 2 · completed Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma · condition mapped CURATED_BROADER · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03450122Phase 1 · completed Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma · condition mapped CURATED_BROADER · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05266196Phase 1/Phase 2 · unknown A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399448Phase 1 · terminated NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02275286Phase 1/Phase 2 · recruiting Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04699292recruiting International Prospective Registry on Local Treatment Approaches in MLS · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02821507Phase 2 · completed Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03989596Phase 2 · unknown Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651375Phase 2 · unknown Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02609984Phase 2 · terminated Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03397186Phase 2 · withdrawn Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01957709early Phase 1 · terminated Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03816475Phase 2 · unknown Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059850Phase 1 · withdrawn NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma · condition mapped ALIAS · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00579501Phase 2 · completed Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00633165Phase 2 · unknown Brostallicin Clinical Trial for Myxoid Liposarcoma · condition mapped ONTOLOGY_EXACT · 31 trials mapped (13 active) | — | — | Myxoid Liposarcoma | 1 | Observed | clinicaltrials | graph → |